Similar articles

• Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.

  Bonow RO, Dilsizian V. Bonow RO, et al. J Nucl Med. 1992 May;33(5):815-8. J Nucl Med. 1992. PMID: 1533248 No abstract available.
• Animal models in radiotracer design of a Tc-labelled myocardial perfusion imaging agent.

  Mousa SA. Mousa SA. Am J Physiol Imaging. 1991;6(1):16-25. Am J Physiol Imaging. 1991. PMID: 1828162 Review. No abstract available.
• ECG-gated and static technetium-99m-SESTAMIBI planar myocardial perfusion imaging: a comparison with thallium-201 and study of observer variabilities.

  Verzijlbergen JF, Cramer MJ, Niemeyer MG, Ascoop CA, Van der Wall EE, Pauwels EK. Verzijlbergen JF, et al. Am J Physiol Imaging. 1990;5(2):60-7. Am J Physiol Imaging. 1990. PMID: 2147553 Clinical Trial.
• Technetium-99m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: comparison between initial (1-hour) and delayed (3-hour) postexercise images.

  Taillefer R, Primeau M, Costi P, Lambert R, Léveillé J, Latour Y. Taillefer R, et al. J Nucl Med. 1991 Oct;32(10):1961-5. J Nucl Med. 1991. PMID: 1833517
• The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.

  Berman DS, Kiat H, Maddahi J. Berman DS, et al. Circulation. 1991 Sep;84(3 Suppl):I7-21. Circulation. 1991. PMID: 1832100 Review.